Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 86 (3) , 431-440
- https://doi.org/10.1016/j.pbb.2006.12.021
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depressionMolecular Psychiatry, 2003
- Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450European Journal of Pharmacology, 2003
- Central vasopressin administration failed to influence anxiety behavior after pinealectomy in ratsPhysiology & Behavior, 2000
- Vasopressin administration modulates anxiety-related behavior in ratsPhysiology & Behavior, 1998
- Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor1 Receptor AntagonistJournal of Medicinal Chemistry, 1997
- Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorderAmerican Journal of Psychiatry, 1997
- Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expressionJournal of Neuroscience, 1995
- Glucocorticoids and the Genesis of Depressive Illness a Psychobiological ModelThe British Journal of Psychiatry, 1994
- Is Corticotropin‐Releasing Factor a Mediator of Stress Responses?aAnnals of the New York Academy of Sciences, 1990
- Clinical and Biochemical Manifestations of DepressionNew England Journal of Medicine, 1988